The Congressional Review Act can axe costly Biden rules.

CVR Energy stock has significantly underperformed, with a -38% return in 2024. Check out why I maintain my Sell rating on CVI ...

Turmoil at the agency could harm not only consumers but also small state-chartered banks, as their bigger rivals gain ...

The financial sector continues to face new rules and government expectations as part of the broader effort to aid the green ...

Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

This paper adds to existing evidence about the cost of increasing regulation in foregone economic growth and highlights the issue for policymakers. The effects of growing regulation on the pace of ...

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...